SPHS
Sophiris Bio, Inc.
SPHS
SPHS
Delisted
SPHS was delisted on the 11th of March, 2020.
34 hedge funds and large institutions have $3.43M invested in Sophiris Bio, Inc. in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
23% less call options, than puts
Call options by funds: $181K | Put options by funds: $235K
Holders
34
Holding in Top 10
–
Calls
$181K
Puts
$235K
Top Buyers
| 1 | +$218K | |
| 2 | +$41K | |
| 3 | +$39.2K | |
| 4 |
Squarepoint
New York
|
+$28K |
| 5 |
Bank of New York Mellon
New York
|
+$26.5K |
Top Sellers
| 1 | -$274K | |
| 2 | -$191K | |
| 3 | -$127K | |
| 4 |
Goldman Sachs
New York
|
-$116K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$55K |